Bradley N Axelrod
Overview
Explore the profile of Bradley N Axelrod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morin R, Axelrod B, Reslan S, Schutte C
Int J Neurosci
. 2018 Sep;
129(3):217-224.
PMID: 30234402
Aims: In neuropsychological evaluations, it is often difficult to ascertain whether poor performance on measures of validity is due to poor effort or malingering, or whether there is genuine cognitive...
2.
Goldman R, Axelrod B, Tandon R, Berent S
Clin Neuropsychol
. 2017 Oct;
7(2):171-178.
PMID: 29022476
The Fuld (1984) cholinergic profile based on the WAIS and WAIS-R age scaled scores has been shown to have moderate sensitivity and varying degrees of specificity in identifying dementia of...
3.
Axelrod B, Jiron C, Henry R
Clin Neuropsychol
. 2017 Oct;
7(2):205-209.
PMID: 29022465
Studies of the potential effect of aging on Wisconsin Card Sorting Test (WCST) performance have found older adults to perform at an impaired level relative to younger adults. This study...
4.
Axelrod B, Goldman R, Woodard J
Clin Neuropsychol
. 2017 Oct;
6(2):143-155.
PMID: 29022449
Neuropsychological instruments continue to proliferate the field, while studies systematically addressing their accuracy and standardization have lagged behind. This paper examines the standard scoring criteria on a widely used neuropsychological...
5.
6.
Morin R, Axelrod B
Clin Neuropsychol
. 2017 Jun;
31(6-7):1087-1099.
PMID: 28632025
Objective: Latent Class Analysis (LCA) was used to classify a heterogeneous sample of neuropsychology data. In particular, we used measures of performance validity, symptom validity, cognition, and emotional functioning to...
7.
Bezdicek O, Stepankova H, Axelrod B, Nikolai T, Sulc Z, Jech R, et al.
Clin Neuropsychol
. 2017 May;
31(sup1):42-60.
PMID: 28534428
Objective: The influence of demographic variables on the Trail Making Test (TMT) performance in older individuals and empirical findings on clinical validity in predementia states, such as Parkinson's disease mild...
8.
Kanser R, Rapport L, Bashem J, Billings N, Hanks R, Axelrod B, et al.
Clin Neuropsychol
. 2017 Jan;
31(3):644-653.
PMID: 28084893
Objective: The present study evaluated strategies used by healthy adults coached to simulate traumatic brain injury (TBI) during neuropsychological evaluation. Method: Healthy adults (n = 58) were coached to simulate...
9.
Spencer R, Waldron-Perrine B, Drag L, Pangilinan P, Axelrod B, Bieliauskas L
Brain Inj
. 2016 Nov;
31(1):32-38.
PMID: 27819490
Objective: This study explored the utility of combining data from measures of performance validity and symptom validity among Veterans undergoing neuropsychological evaluation for mild traumatic brain injury (mTBI). Background: Persistent...
10.
Lippa S, Axelrod B, Lange R
J Clin Exp Neuropsychol
. 2016 May;
38(7):721-9.
PMID: 27159359
Introduction: The Mild Brain Injury Atypical Symptoms (mBIAS) scale was developed as a symptom validity test (SVT) for use with patients following mild traumatic brain injury. This study was the...